Shares of SenesTech Inc (NASDAQ:SNES) saw unusually-high trading volume on Monday . Approximately 1,242,122 shares were traded during mid-day trading, an increase of 391% from the previous session’s volume of 252,951 shares.The stock last traded at $1.36 and had previously closed at $1.23.

Separately, Zacks Investment Research raised SenesTech from a “sell” rating to a “hold” rating in a research note on Wednesday, January 16th.

The company has a market capitalization of $31.90 million, a price-to-earnings ratio of -1.18 and a beta of 1.28. The company has a debt-to-equity ratio of 0.03, a current ratio of 9.02 and a quick ratio of 7.88.

An institutional investor recently raised its position in SenesTech stock. Vanguard Group Inc boosted its position in shares of SenesTech Inc (NASDAQ:SNES) by 35.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 162,808 shares of the company’s stock after buying an additional 42,500 shares during the period. Vanguard Group Inc owned approximately 0.69% of SenesTech worth $112,000 as of its most recent SEC filing. Institutional investors and hedge funds own 8.39% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “SenesTech (SNES) Sees Strong Trading Volume” was first posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at

SenesTech Company Profile (NASDAQ:SNES)

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. The company focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment.

See Also: Hedge Funds – How They Work For Investors

Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with's FREE daily email newsletter.